GLP-3 RT 100mg Peptides
Precision starts at the source, and this GLP-3 RT lyophilized peptide is prepared for researchers who demand consistency and clarity in every lot.
The Primavora GLP-3 RT peptide arrives as a lyophilized vial designed for controlled laboratory workflows. This research-grade format contains a total of 100mg of the GLP-3 RT active peptide, providing a dependable option for method development, assay design, and exploratory studies. Also referenced as glucagon-like peptide-3 RT in literature, this compound is presented to support rigorous, well-documented work under qualified lab conditions.
- Each vial contains 100mg of GLP-3 RT, suitable for advanced investigations into glucagon-like peptide signaling, receptor interaction profiling, and structure-activity evaluations.
Engineered for laboratory use, the lyophilized presentation supports careful handling, controlled reconstitution, and precise aliquoting according to institutional protocols. Researchers value the clean presentation, reliable lot-to-lot performance, and straightforward integration into established analytical setups. Whether incorporated into screening workflows or used to refine procedural parameters, this vial is built to enable consistent, traceable research execution.
Every Primavora peptide is handled with strict attention to purity and identity. Lots are verified by analytical methods such as HPLC for purity assessment and LC-MS for identity confirmation, then documented with traceable lot numbers. Produced in the USA under disciplined quality controls, each vial is packaged to protect integrity from receipt through storage and daily bench use. A certificate of analysis (COA) is available to support internal compliance and documentation requirements.
Trust, transparency, and control guide our approach: stable sourcing, meticulous handling, and clear documentation at every step. This GLP-3 RT lyophilized vial reflects that commitment—research-ready, clearly labeled, and built around standards that put data quality first.
For laboratory research use only. Not for human consumption, medical, clinical, or veterinary use. Handle only by qualified personnel in appropriate facilities and follow all applicable regulations and safety procedures.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-3 RT?
GLP-3 RT is not a standard pharmacology name, and on research-vendor sites it is often used as shorthand for a retatrutide-style multi-incretin compound. Because that naming is vendor-dependent, the exact identity should be checked on the product page or certificate of analysis. It should therefore be described cautiously as a multi-pathway metabolic research compound.
What is GLP-3 RT typically studied for?
Compounds sold under this label are generally discussed for appetite, glucose regulation, energy expenditure, and multi-receptor incretin signaling. A careful FAQ should avoid presenting the shorthand as if it were a formal drug name and instead tell readers to verify the exact active ingredient before designing research around it.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Prima Vora are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
